Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Polycystic Ovary Syndrome (PCOS) is a common but often undiagnosed disorder in women that can cause irregular periods, infertility, and other symptoms, and can be managed with lifestyle changes, medication, and sometimes surgery.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Most women lack knowledge about androgens and their excess symptoms.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Eating disorders can cause various hair problems, and while hair loss in these disorders is linked to metabolic syndrome, treatment focuses on specific medications and lifestyle changes for the syndrome.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.